CordenPharma Expands Peptide Platform with Greenfield Facility Construction in Switzerland
The company's ambitious expansion plans are set to propel its Peptide Platform business beyond the EUR 1 billion sales milestone by 2028, reinforcing CordenPharma's position as a market leader in integrated supply of small to large-scale services from APIs to Drug Products, for both Injectable and Oral Peptides.
Greenfield Facility Construction | 07/03/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy